Ally Bridge Group (Ny) LLC Geron Corp Transaction History
Ally Bridge Group (Ny) LLC
- $88.1 Million
- Q4 2024
A detailed history of Ally Bridge Group (Ny) LLC transactions in Geron Corp stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 1,074,824 shares of GERN stock, worth $1.86 Million. This represents 4.32% of its overall portfolio holdings.
Number of Shares
1,074,824
Previous 1,331,053
19.25%
Holding current value
$1.86 Million
Previous $6.04 Million
37.04%
% of portfolio
4.32%
Previous 4.29%
Shares
7 transactions
Others Institutions Holding GERN
# of Institutions
306Shares Held
465MCall Options Held
1.07MPut Options Held
648K-
Black Rock Inc. New York, NY46.6MShares$80.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA33.5MShares$58 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA30MShares$51.9 Million1.72% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$47.1 Million18.81% of portfolio
-
State Street Corp Boston, MA27.2MShares$47 Million0.0% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $654M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...